Warren James Huff - Chief Executive Officer, Reata Pharmaceuticals Inc

As of January 6, 2021


Warren James Huff Net Worth

  • Net worth is estimated to be at least $19.92M
  • Owns at least 1,583 units of Reata Pharmaceuticals Inc stock
  • Sold an estimated value of $19.75M in the last 5 years at Reata Pharmaceuticals Inc

Warren James Huff Compensation at Reata Pharmaceuticals Inc in 2020

  • Earned a $636,400 salary and a $413 bonus
  • Received a total compensation of $6,396,130

Warren James Huff Trading

  • Largest purchase of shares was 179,823 units , worth over $1.25M on June 2, 2016
  • Largest sale of shares was 81,657 units , worth over $14.29M on November 10, 2020
  • In total has made about 11 transactions over 5 years
  • Usually trades in January and December, with the busiest year in 2019 and 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Warren James Huff Mailing Address

  • Mailing address is C/o Reata Pharmaceuticals, Inc. 2801 Gateway Dr. Suite 150 Irving TX 75063 TX

Reata Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
J. Warren Huff 2020 $636,400 $413,660 - $5,000 $5,000 $6,396,130
J. Warren Huff 2019 $578,500 $600,540 - $16,715 $16,715 $5,542,605
J. Warren Huff 2018 $534,000 $400,500 - - - $934,500
Manmeet S. Soni 2020 $545,900 $445,700 - $136,125 $136,125 $4,465,894
Manmeet S. Soni 2019 $179,385 $408,873 - $70,243 $70,243 $12,261,587
Dawn C. Bir 2020 $422,000 $239,900 - $5,000 $5,000 $3,871,542
Dawn C. Bir 2019 $375,100 $287,550 - $3,500 $3,500 $1,975,899
Colin J. Meyer, M.D. 2020 $513,951 $381,400 - - - $4,233,520
Colin J. Meyer, M.D. 2019 $445,600 $389,467 - - - $2,182,780
Colin J. Meyer, M.D. 2018 $417,000 $208,500 - - - $625,500
Michael D. Wortley 2020 $421,100 $339,500 - - - $3,965,242
Michael D. Wortley 2019 $382,800 $341,400 - - - $2,033,949
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm

Reata Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 60,000 units sold on June 16, 2021 by John Colin Meyer worth over $8.55M
  • In the last 5 years, insiders at Reata Pharmaceuticals Inc sold an estimated value of $113.89M and bought an estimated value of $136.9M
  • The most active traders are Douglas Jason Wilson, Executive VP Operations,  Elaine Castellanos, VP,  and R. Kent McGaughy Jr., Director
  • Insider trading is most common in June, with the busiest year in 2019

REATA PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1